Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1Other 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 6Carcinoma, Hepatocellular 6Stomach Neoplasms 4Rectal Neoplasms 4Gastro-enteropancreatic neuroendocrine tumor 4Esophageal Neoplasms 4Diarrhea 4Weight Loss 3Pancreatic Neoplasms 3Neuroendocrine Tumors 3Colonic Neoplasms 3Ovarian Neoplasms 2Neoplasms 2Malnutrition 2Duodenal Neoplasms 2Vulvar Neoplasms 1Vomiting 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Pancreatitis 1Pancreatic Neuroendocrine Tumor G2 1Pancreatic Intraductal Neoplasms 1Nutrition Disorders 1Neoplastic Cells, Circulating 1Nausea 1Liver Neoplasms 1Intestinal Obstruction 1Insulin Resistance 1

Interventions

Octreotide 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intestinal Obstruction × Octreotide × Gastrointestinal × Clear all
NCT00004895 2012-06-06

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Northwestern University

Phase 2 Completed
GastrointestinalGynecologicOtherSarcoma

Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Colonic Neoplasms, Constipation, Intestinal Obstruction, Nausea, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Vomiting, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡